Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176203562> ?p ?o ?g. }
- W3176203562 endingPage "107917" @default.
- W3176203562 startingPage "107917" @default.
- W3176203562 abstract "Several studies have demonstrated that rheumatic diseases, including Juvenile Idiopathic Arthritis (JIA), are associated with anxiety-like behavior and a cognitive decline. Infliximab, a Tumor Necrosis Factor-alpha (TNF-a) inhibitor, and tocilizumab, an antibody against Interleukin-6 (IL-6) receptor, are commonly used in the treatment of JIA. Here, we aimed to evaluate the effects of infliximab and tocilizumab on anxiety symptoms and cognitive function in a juvenile model of severe autoimmune arthritis. We found that both infliximab and tocilizumab improved anxiety-like behavior in the elevated-plus and elevated-zero maze tests. Tocilizumab, also, improved cognitive performance in the passive avoidance and olfactory social memory tests. Histological examination showed that anti-cytokine treatment reversed the histopathological alterations in the brain induced by arthritis. Further, infliximab and tocilizumab treatment increased Brain-Derived Neurotrophic Factor (BDNF) expression in the hippocampal and amygdaloid area of rat brain. In summary, our findings provide evidence that infliximab and tocilizumab have a beneficial effect on anxiety-like behavior and cognitive function and alleviate neuropathological alterations in a juvenile rat model of severe arthritis, suggesting that inhibition of TNF-a and IL-6 in the periphery, may be associated with a mood and memory enhancement in JIA patients." @default.
- W3176203562 created "2021-07-05" @default.
- W3176203562 creator A5025201893 @default.
- W3176203562 creator A5027547265 @default.
- W3176203562 creator A5037657056 @default.
- W3176203562 creator A5038249111 @default.
- W3176203562 creator A5054691521 @default.
- W3176203562 creator A5056638752 @default.
- W3176203562 date "2021-10-01" @default.
- W3176203562 modified "2023-10-18" @default.
- W3176203562 title "Infliximab and tocilizumab reduce anxiety-like behavior, improve cognitive performance and reverse neuropathological alterations in juvenile rats with severe autoimmune arthritis" @default.
- W3176203562 cites W1964160578 @default.
- W3176203562 cites W1967075670 @default.
- W3176203562 cites W1969398179 @default.
- W3176203562 cites W1970060526 @default.
- W3176203562 cites W1982387056 @default.
- W3176203562 cites W1983811158 @default.
- W3176203562 cites W1986898121 @default.
- W3176203562 cites W1987317482 @default.
- W3176203562 cites W1987565381 @default.
- W3176203562 cites W1989633548 @default.
- W3176203562 cites W1993537924 @default.
- W3176203562 cites W1993693608 @default.
- W3176203562 cites W1996916154 @default.
- W3176203562 cites W2001308670 @default.
- W3176203562 cites W2002250647 @default.
- W3176203562 cites W2008555422 @default.
- W3176203562 cites W2015836376 @default.
- W3176203562 cites W2018635339 @default.
- W3176203562 cites W2026183163 @default.
- W3176203562 cites W2032243314 @default.
- W3176203562 cites W2047782979 @default.
- W3176203562 cites W2048734836 @default.
- W3176203562 cites W2049069390 @default.
- W3176203562 cites W2049361817 @default.
- W3176203562 cites W2056288249 @default.
- W3176203562 cites W2075591761 @default.
- W3176203562 cites W2077756971 @default.
- W3176203562 cites W2085100284 @default.
- W3176203562 cites W2085227738 @default.
- W3176203562 cites W2107277218 @default.
- W3176203562 cites W2109172889 @default.
- W3176203562 cites W2122305679 @default.
- W3176203562 cites W2134389576 @default.
- W3176203562 cites W2146607274 @default.
- W3176203562 cites W2161787322 @default.
- W3176203562 cites W2165520691 @default.
- W3176203562 cites W2266543467 @default.
- W3176203562 cites W2297656453 @default.
- W3176203562 cites W2338607639 @default.
- W3176203562 cites W2481064166 @default.
- W3176203562 cites W2513996964 @default.
- W3176203562 cites W2582584573 @default.
- W3176203562 cites W2588266087 @default.
- W3176203562 cites W2600458201 @default.
- W3176203562 cites W2612754606 @default.
- W3176203562 cites W2618179290 @default.
- W3176203562 cites W2618932078 @default.
- W3176203562 cites W2698307513 @default.
- W3176203562 cites W2777753808 @default.
- W3176203562 cites W2783610566 @default.
- W3176203562 cites W2799772642 @default.
- W3176203562 cites W2911185470 @default.
- W3176203562 cites W2912456649 @default.
- W3176203562 cites W2912610429 @default.
- W3176203562 cites W2948181434 @default.
- W3176203562 cites W2971949693 @default.
- W3176203562 cites W2982690425 @default.
- W3176203562 cites W2983291704 @default.
- W3176203562 cites W2998525192 @default.
- W3176203562 cites W3011737466 @default.
- W3176203562 cites W3035460029 @default.
- W3176203562 cites W4234521475 @default.
- W3176203562 cites W4237169206 @default.
- W3176203562 cites W4245492581 @default.
- W3176203562 doi "https://doi.org/10.1016/j.intimp.2021.107917" @default.
- W3176203562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34217991" @default.
- W3176203562 hasPublicationYear "2021" @default.
- W3176203562 type Work @default.
- W3176203562 sameAs 3176203562 @default.
- W3176203562 citedByCount "2" @default.
- W3176203562 countsByYear W31762035622022 @default.
- W3176203562 countsByYear W31762035622023 @default.
- W3176203562 crossrefType "journal-article" @default.
- W3176203562 hasAuthorship W3176203562A5025201893 @default.
- W3176203562 hasAuthorship W3176203562A5027547265 @default.
- W3176203562 hasAuthorship W3176203562A5037657056 @default.
- W3176203562 hasAuthorship W3176203562A5038249111 @default.
- W3176203562 hasAuthorship W3176203562A5054691521 @default.
- W3176203562 hasAuthorship W3176203562A5056638752 @default.
- W3176203562 hasConcept C126322002 @default.
- W3176203562 hasConcept C17991360 @default.
- W3176203562 hasConcept C203014093 @default.
- W3176203562 hasConcept C2777077863 @default.
- W3176203562 hasConcept C2777138892 @default.
- W3176203562 hasConcept C2777178219 @default.
- W3176203562 hasConcept C2777575956 @default.
- W3176203562 hasConcept C71924100 @default.